Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials
The objective of this analysis was to compare the anti-HPV GMTs and their distribution after a 6-month or a 3-8 -y interval between two HPV vaccine doses. The results from two clinical trials, conducted by the same team in the same region, with serological assays performed at the same laboratory usi...
Saved in:
Main Authors: | Vladimir Gilca (Author), Chantal Sauvageau (Author), Gitika Panicker (Author), Gaston De Serres (Author), John Schiller (Author), Manale Ouakki (Author), Elisabeth R. Unger (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials
by: Chantal Sauvageau, et al.
Published: (2020) -
Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later - an exploratory study
by: Vladimir Gilca, et al.
Published: (2019) -
Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine
by: Geneviève Deceuninck, et al.
Published: (2018) -
Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada
by: Duval Bernard, et al.
Published: (2007) -
Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women
by: Chantal Sauvageau, et al.
Published: (2021)